Tag: hematocrit test devices market share

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The hematocrit test devices market has experienced notable growth recently, driven by increasing healthcare needs and advancements in diagnostic technologies. As conditions related to blood health become more prevalent, the demand for accurate and efficient hematocrit testing solutions is rising. This overview explores the market’s current size, growth factors, key players, and evolving innovations shaping its future.

Current Market Size and Projected Growth of the Hematocrit Test Devices Market

The hematocrit test devices market demonstrated strong expansion from $4.91 billion in 2025 to $5.22 billion in 2026, growing at a compound annual growth rate (CAGR) of 6.4%. This growth during the past years has been driven by a rise in anemia and blood disorder cases, increasing diagnostic testing in hospitals and laboratories, higher demand for screening blood donors, the broadening scope of emergency and trauma care, and a stronger awareness of hematocrit monitoring in clinical settings. Looking ahead, the market is forecasted to reach $6.47 billion by 2030, growing at a CAGR of 5.5%. This anticipated growth will be fueled by the expanding need for point-of-care diagnostics, the rising incidence of chronic and lifestyle-related illnesses, the growth of decentralized health services and home-testing options, increased investments in diagnostic infrastructure, and a growing emphasis on early disease detection and preventive healthcare.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp

Factors Supporting Demand Growth in the Hematocrit Test Devices Market

One key element bolstering the hematocrit test devices market is the rising occurrence of blood disorders worldwide. These disorders impact various blood components such as red and white blood cells, platelets, and plasma. Their increasing prevalence is influenced by genetic factors, environmental pollution, and lifestyle changes. Hematocrit test devices play a vital role in measuring the proportion of red blood cells in blood, providing essential data on a patient’s hematologic status. For instance, the American Cancer Society’s January 2024 report expects about 62,770 new leukemia cases in the US in 2024, with approximately 23,670 deaths. Acute myeloid leukemia (AML) accounts for roughly 20,800 new cases, primarily in adults, and about 11,220 deaths mostly within this group. Such statistics highlight how the rising number of blood disorders is steering demand for hematocrit testing technologies.

Additional Drivers Accelerating Hematocrit Test Devices Market Demand

Moreover, the growing awareness of hematocrit testing’s importance in routine health monitoring and chronic disease management continues to propel the market. The expansion of healthcare infrastructure and the integration of advanced diagnostic tools contribute further. Emergency care settings increasingly rely on rapid hematocrit testing to guide treatment decisions, enhancing patient outcomes and efficiency.

Access The Complete Hematocrit Test Devices Market Report:

https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

Hematocrit Test Devices Market Segmentation and Revenue Generators

The hematocrit test devices market is categorized into several segments to better understand its scope:

1) Product types: Hematocrit Test Meter, Hematocrit Test Analyzer, and Reagents and Consumables.

2) Applications: Anemia, Polycythemia Vera, Congenital Heart Diseases, and other uses.

3) End-Users: Hospitals and Ambulatory Surgical Centers, Clinics, Diagnostic and Pathology Labs, and various other end-users.

Within product subcategories, hematocrit test meters include handheld, portable, desktop, point-of-care, digital, and battery-powered variants. Hematocrit analyzers range from automated, benchtop, semi-automated, microhematocrit, high-throughput, to compact analyzers. Reagents and consumables consist of test strips, pipettes and capillaries, blood collection tubes, quality control reagents, calibration standards, and disposable kits.

Technological Developments and Innovations Driving Market Transformation

Leading companies in the hematocrit test devices sector are advancing their offerings by focusing on user-friendly platforms suited for medium-volume laboratories. These systems emphasize ease of use with minimal training required. For example, in March 2024, Mindray introduced the BC-700 Series, a compact hematology analyzer combining CBC and ESR testing in one device designed for smaller labs. It delivers results in 1.5 minutes, improving workflow efficiency. Its SF Cube 3D analysis technology allows precise cell differentiation, and the inclusion of the PLT-H parameter enhances platelet counting. Combining multiple tests into a single unit reduces costs for equipment and consumables. Available in open vial and autoloader formats, the BC-700 Series offers reliable, automated, and space-saving testing with strong consistency compared to traditional methods, alongside improved safety and repeatability.

Key Companies Leading the Hematocrit Test Devices Market Competition

The market features several prominent players, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory LP, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, and Mikroscan Technologies Inc. These organizations compete by innovating product features, expanding distribution networks, and enhancing service capabilities.

Geographical Market Presence and Regional Leadership in Hematocrit Testing

In 2025, North America held the largest share of the hematocrit test devices market. However, the Asia-Pacific region is expected to exhibit the fastest growth rate during the forecast period. The market report covers regions such as Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a detailed global perspective on market trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Hematocrit Test Devices Market Progress Between 2026 And 2030?

The market for hematocrit test devices has demonstrated strong growth in recent years. It is anticipated to expand from $4.91 billion in 2025 to $5.22 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.4%. This historic growth can be attributed to the increasing prevalence of anemia and blood disorders, an uptick in hospital and laboratory diagnostic testing, a rising demand for blood donor screening, the expansion of emergency and trauma care services, and a growing awareness of hematocrit monitoring in clinical practice.

The hematocrit test devices market size is projected to experience robust expansion over the coming years. It is anticipated to reach $6.47 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the forecast period include the escalating demand for point-of-care diagnostics, the rising prevalence of chronic and lifestyle-related illnesses, the expansion of decentralized healthcare and home testing solutions, increasing investments in diagnostic infrastructure, and a heightened emphasis on early disease detection and preventive healthcare. Key trends observed within the forecast period encompass the increasing uptake of point-of-care hematocrit testing devices, a growing need for swift and precise blood parameter evaluation, the expanding utilization of portable and handheld hematocrit meters, the broadening application of hematocrit testing in emergency and critical care environments, and a reinforced emphasis on routine screening and ongoing management of chronic diseases.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp

What Key Drivers Are Fueling The Growth Of The Hematocrit Test Devices Market?

The rising prevalence of blood disorders is anticipated to boost the growth of the hematocrit test devices market moving forward. A blood disorder describes a condition that impacts human blood components, including red blood cells, white blood cells, platelets, and blood plasma. The growing commonality of blood disorders is linked to several factors, such as genetic predispositions, environmental pollution, and shifts in lifestyle. Hematocrit test devices are primarily utilized to determine the volume percentage of red blood cells in whole blood, providing crucial information regarding a patient’s hematological health. For instance, in January 2024, a report from the American Cancer Society, a US-based non-profit organization, indicated that approximately 62,770 new cases of leukemia across all types are projected in the United States in 2024, leading to an estimated 23,670 deaths. Among these cases, around 20,800 new instances of acute myeloid leukemia (AML) are expected, predominantly affecting adults, with approximately 11,220 deaths attributed to AML, nearly exclusively among adult patients. Therefore, the increasing occurrences of blood disorders are driving the expansion of the hematocrit test devices market.

What Segment Categories Shape The Hematocrit Test Devices Market Segment Landscape?

The hematocrit test devices market covered in this report is segmented –

1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables

2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications

3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users

Subsegments:

1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters

2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers

3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables

What Trends Are Influencing The Hematocrit Test Devices Market?

Leading enterprises within the hematocrit test device market are prioritizing cutting-edge technologies, particularly user-friendly platforms tailored for laboratories with moderate testing volumes. Such platforms are systems designed with straightforward, intuitive features that enable rapid operation with minimal prior instruction. For instance, in March 2024, Mindray, a health technology firm based in China, unveiled the BC-700 Series—a streamlined, all-in-one hematology analyzer suitable for small to medium-sized laboratories. This device integrates both CBC and ESR testing, providing results in a mere 1.5 minutes, thereby enhancing operational efficiency and workflow. It incorporates SF Cube 3D analysis technology for precise cell differentiation and features the PLT-H parameter to improve platelet count accuracy. By merging CBC and ESR into a single unit, it helps reduce expenses related to equipment and consumables. Offered in both open vial and autoloader configurations, the BC-700 Series ensures dependable, automated, and compact testing solutions, exhibiting a strong correlation with conventional methodologies, alongside improved safety and repeatability.

Who Are The Companies Operating Across The Hematocrit Test Devices Market Value Chain?

Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory LP, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

Get The Full Hematocrit Test Devices Market Report:

https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

Which Region Leads The Hematocrit Test Devices Market In Overall Market Size?

North America was the largest region in the hematocrit test devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hematocrit Test Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=15582&type=smp

Browse Through More Reports Similar to the Global Hematocrit Test Devices Market 2026, By The Business Research Company

Hematology Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

Dermatological Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/dermatological-drugs-global-market-report

Hemato Oncology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Hematocrit Test Devices Market by the end of 2030?

The hematocrit test devices market size has experienced robust expansion in recent years. It is expected to see an increase from $4.91 billion in 2025 to reach $5.22 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.4%. This growth observed in the historic period can be ascribed to the increasing prevalence of anemia and blood disorders, the expansion in hospital and laboratory diagnostic testing, a rising demand for blood donor screening, the broadening of emergency and trauma care services, and a growing awareness of hematocrit monitoring in clinical practice.

The hematocrit test devices market is projected to experience substantial expansion in the coming years, with its value anticipated to reach $6.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.5%. This growth during the forecast period is attributable to several factors, including an escalating demand for point-of-care diagnostics, the rising prevalence of chronic and lifestyle-related illnesses, the expansion of decentralized healthcare systems and at-home testing, increasing financial commitments in diagnostic infrastructure, and a heightened emphasis on early disease identification and preventive health measures. Key trends shaping the forecast period encompass the increasing integration of point-of-care hematocrit testing devices, a heightened need for swift and precise blood parameter evaluations, the growing utilization of portable and handheld hematocrit meters, the broadening application of hematocrit testing in emergency and critical care environments, and an intensified focus on routine health screenings and monitoring of chronic conditions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp

What Drivers Are Shaping Future Opportunities In The Hematocrit Test Devices Market?

An increase in blood disorder occurrences is projected to stimulate expansion within the hematocrit test devices market in the future. A blood disorder represents a medical condition impacting the various constituents of human blood, such as red blood cells, white blood cells, platelets, and blood plasma. The rising prevalence of blood disorders can be attributed to multiple factors, including inherited genetic tendencies, environmental contamination, and shifts in lifestyle habits. These hematocrit test devices serve a primary function in quantifying the volumetric proportion of red blood cells within whole blood, thereby offering vital insights into a patient’s hematological well-being. As an illustration, in January 2024, a report from the American Cancer Society, a non-profit organization based in the US, indicated that around 62,770 new cases of all leukemia types are foreseen in the United States in 2024, potentially resulting in an estimated 23,670 fatalities. Within this total, approximately 20,800 new occurrences of acute myeloid leukemia (AML) are projected, predominantly impacting adults, with about 11,220 deaths linked to AML, almost entirely among adult patients. Consequently, the increasing incidence of blood disorders is fueling the expansion of the hematocrit test devices market.

Which Segments Are Gaining Traction In The Hematocrit Test Devices Market?

The hematocrit test devices market covered in this report is segmented –

1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables

2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications

3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users

Subsegments:

1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters

2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers

3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables

What Industry Trends Are Transforming The Hematocrit Test Devices Market?

Leading companies in the hematocrit test device market are focusing on advanced technologies, including user-friendly platforms designed for medium-volume laboratories. An easy-to-use platform is a system built with intuitive features that enable quick operation with minimal training. For instance, in March 2024, Mindray, a China-based health technology company, introduced the BC-700 Series—a compact, integrated hematology analyzer for small to medium-sized labs that combines CBC and ESR testing into one device. It delivers results in just 1.5 minutes, improving efficiency and workflow. The system utilizes SF Cube 3D analysis technology for accurate cell differentiation and includes the PLT-H parameter for enhanced platelet counting. By integrating CBC and ESR into a single unit, it lowers equipment and consumable costs. Available in both open vial and autoloader versions, the BC-700 Series offers reliable, automated, space-saving testing with strong correlation to traditional methods and increased safety and repeatability.

Who Are The Primary Competitors In The Global Hematocrit Test Devices Market?

Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory LP, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Hematocrit Test Devices Market?

North America was the largest region in the hematocrit test devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hematocrit Test Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15582&type=smp

Browse Through More Reports Similar to the Global Hematocrit Test Devices Market 2026, By The Business Research Company

Hematology Diagnostic Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

Dermatological Drugs Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dermatological-drugs-global-market-report

Hemato Oncology Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the hematocrit test devices market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Hematocrit Test Devices Market Now And By 2029?

The market for hematocrit test devices has experienced robust expansion recently. Its valuation is projected to increase from $4.63 billion in 2024 to $4.91 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 6.0%. This historical growth was driven by several factors, including enhanced public knowledge of anemia, deficiencies in iron and vitamins, a higher prevalence of chronic diseases, a significant increase in government funding, and overall population expansion.

The hematocrit test devices market size is anticipated to undergo significant expansion in the coming years. This market is projected to escalate to $6.19 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.0%. The growth expected during the forecast period can be attributed to the increasing prevalence of anemia, a rise in blood disorder cases, an expanding geriatric population, a growing emphasis on health and fitness, and a broadening need for cardiovascular diagnostic equipment. Dominant trends in the forecast period encompass the introduction of advanced solutions, technological progress in medical science, the development of new efficient and innovative products, technical improvements in hematocrit testing, and overall advancements within the healthcare sector.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp

Which Long-Term Drivers Are Expected To Sustain The Hematocrit Test Devices Market?

The rising incidence of blood disorders is anticipated to fuel the expansion of the hematocrit test devices market in the coming period. A blood disorder is defined as a condition that impacts the various components of human blood, including red blood cells, white blood cells, platelets, and blood plasma. These disorders are becoming more prevalent due to a combination of factors such as genetic predispositions, environmental pollution, and shifts in lifestyle. Hematocrit test devices serve a primary function in measuring the volume percentage of red blood cells within whole blood, thereby offering crucial insights into a patient’s hematological health. Illustratively, in January 2024, a report from the American Cancer Society, a non-profit organization based in the US, estimated approximately 62,770 new cases of leukemia (all types) in the United States for 2024, which are expected to lead to about 23,670 deaths. Among these, roughly 20,800 new instances of acute myeloid leukemia (AML) are foreseen, predominantly affecting adults, with roughly 11,220 deaths attributed to AML, almost exclusively among adult patients. Thus, the increasing number of blood disorder cases is significantly contributing to the growth of the hematocrit test devices market.

How Is The Hematocrit Test Devices Market Classified By Different Segments?

The hematocrit test devicesmarket covered in this report is segmented –

1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables

2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications

3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users

Subsegments:

1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters

2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers

3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables

What Current And Upcoming Trends Are Shaping The Hematocrit Test Devices Market?

Leading companies in the hematocrit test device market are developing innovative products, such as complete blood count (CBC) hematology analyzers, to deliver quantitative and qualitative information regarding these blood cells. A complete blood count (CBC) hematology analyzer functions as an automated instrument for measuring and analyzing various blood components, including red blood cells (RBCs), white blood cells (WBCs), and platelets. For instance, in March 2022, Mindray Medical International Limited, a China-based medical device company, introduced the BC-700 hematology analyzer series. This complete blood count (CBC) hematology analyzer incorporates both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. The BC-700 hematology analyzer, along with its counterparts BC-720, BC-760, and BC-780, constitutes a series specifically designed to equip medium-volume laboratories with cutting-edge diagnostic technologies comparable to those available in premium products. The BC-700 Series is a more compact version of the high-end BC-6000 Series, built upon the same platform and distinguished by Mindray’s SF Cube 3D analysis technology. The SF Cube technology employs fluorescence and bi-angular laser scatter signals to analyze target cells in three dimensions.

Who Are The Primary Market Leaders In The Hematocrit Test Devices Market?

Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company (BD), Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, Heska Corporation, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory Lp, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Hematocrit Test Devices Market?

North America was the largest region in the hematocrit test devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15582&type=smp

Browse Through More Reports Similar to the Global Hematocrit Test Devices Market 2025, By The Business Research Company

Hematopoietic Stem Cell Transplantation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report

Hematology Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

Hematology Analyzers And Reagents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Hematocrit Test Devices Market?

Market valuation for hematocrit testing instruments has demonstrated robust expansion over the last few years, projected to escalate from a figure of $4.63 billion in 2024 to $4.91 billion in 2025, reflecting a consistent annual growth rate (CAGR) of 6.0%; this upward trajectory during the past period is largely attributable to heightened public consciousness concerning conditions like anemia and deficiencies in essential elements such as iron and vitamins, alongside a greater prevalence of long-term health issues, augmented financial support from governmental bodies, and an overall expanding populace.

The market encompassing hematocrit testing apparatus is projected to experience considerable expansion across the forthcoming years, reaching a valuation of $6.19 billion by 2029, driven by a solid compound annual growth rate (CAGR) of 6.0%, with this upswing being fueled by a rising incidence of anemia, an increase in diagnosed blood-related conditions, the swelling ranks of the elderly demographic, heightened attention toward physical wellness and fitness regimens, and an expanding necessity for cardiovascular diagnostic tools, while key market movements shaping this period involve the launch of state-of-the-art methodologies, progress in medical technology, the emergence of novel, effective, and inventive items, technological strides in the field of hematocrit analysis, and general improvements within the broader healthcare industry.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp

Which Drivers Are Shaping The Hematocrit Test Devices Industry’s Market Share?

Anticipated increases in the incidence of various blood-related ailments are set to fuel the expansion of the market for hematocrit testing equipment. Blood disorders encompass conditions impacting the constituents of human blood, such as platelets, white blood cells, red blood cells, and the blood plasma itself. Factors such as inherited susceptibilities, environmental contamination, and shifts in daily habits are contributing to the rising prevalence of these conditions. Hematocrit testing apparatus serves the essential function of quantifying the proportion of red blood cells relative to the total volume of whole blood, thereby supplying vital insights into an individual’s hematological status. To illustrate this trend, data released in January 2024 by the American Cancer Society, a US-based charitable organization, projected roughly 62,770 new diagnoses across all leukemia types within the United States for that year, with an estimated 23,670 fatalities resulting. Specifically, about 20,800 new diagnoses of acute myeloid leukemia (AML) are foreseen, mainly impacting the adult population, responsible for approximately 11,220 mortalities, nearly all of which are adult cases. Consequently, the escalating figures of blood disorders are acting as a stimulus for the advancement of the market for hematocrit testing devices.

What Are The Different Segment Classifications Within The Hematocrit Test Devices Market?

The hematocrit test devicesmarket covered in this report is segmented –

1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables

2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications

3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users

Subsegments:

1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters

2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers

3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables

Which Market Trends Are Creating New Opportunities In The Hematocrit Test Devices Industry?

Leading corporations within the hematocrit testing apparatus sector are actively engineering novel offerings, such as comprehensive blood count (CBC) hematology analyzers, which furnish both numerical and descriptive data regarding blood corpuscles; these automated tools are designed to quantify and examine diverse blood elements like red blood cells, white blood cells, and platelets. Demonstrating this trend, in March 2022, Mindray Medical International Limited, a firm situated in China specializing in medical apparatus, introduced the BC-700 hematology analyzer family, a CBC analyzer series integrating both complete blood count and erythrocyte sedimentation rate assessments, where the BC-700, alongside the BC-720, BC-760, and BC-780 models, represents a collection engineered to equip mid-sized diagnostic facilities with advanced analytical capabilities mirroring those inherent in top-tier devices, notably sharing the same foundational architecture as the superior BC-6000 Series but in a reduced physical footprint, and is characterized by Mindray’s SF Cube 3D analytical methodology, which employs fluorescence alongside dual-angle laser diffraction to achieve three-dimensional appraisals of the examined cells.

Which Major Firms Are Strengthening Their Position In The Hematocrit Test Devices Industry?

Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company (BD), Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, Heska Corporation, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory Lp, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

How Is Hematocrit Test Devices Market Demand Varying Across Different Regions?

North America was the largest region in the hematocrit test devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Hematocrit Test Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15582&type=smp

Browse Through More Reports Similar to the Global Hematocrit Test Devices Market 2025, By The Business Research Company

Hematopoietic Stem Cell Transplantation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report

Hematology Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

Hematology Analyzers And Reagents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Hematocrit Test Devices Market Size From 2025 to 2034?

The market size of hematocrit test devices has seen robust growth in the past years. This market is anticipated to expand from a size of $4.63 billion in 2024 to $4.91 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%. The historic growth can be credited to an increased awareness about anemia, deficiencies in iron and vitamins, a rise in chronic illness cases, an upsurge in government funding, and a surge in population.

The market for hematocrit test devices is predicted to experience significant expansion in the approaching years. Projected to reach a value of $6.19 billion by 2029, the market is expected to achieve a compound annual growth rate (CAGR) of 6.0%. This anticipated growth during the forecast period is linked to numerous factors, including increased instances of anemia and blood disorders, a growing elderly population, heightened emphasis on health and fitness, and the expanding requirement for cardiovascular diagnostic tools. Crucial trends identified for the forecast period encompass the emergence of groundbreaking solutions, technological progress in the field of medical science, the development of newly efficient and innovative products, technological advancements specific to hematocrit testing, and ongoing progress in the healthcare sector.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp

Which Factors and External Forces Are Driving Demand in the Hematocrit Test Devices Market?

The rise in blood disorders is projected to fuel the expansion of the hematocrit test devices market in the future. Blood disorders, which can affect red and white blood cells, platelets, and blood plasma, are on the rise due to several factors such as genetic predispositions, environmental pollution, and changes in lifestyle. Hematocrit test devices, which are primarily used to calculate the volume proportion of red blood cells in the blood, provide vital data regarding a patient’s hematology health. For instance, a report by the American Cancer Society, a non-profit organization based in the U.S., projected that roughly 62,770 new cases of all types of leukemia would occur in the United States in January 2024, translating to an estimated 23,670 fatalities. Among these cases, an estimated 20,800 new cases of acute myeloid leukemia (AML) are expected, predominantly in adults, with about 11,220 deaths as a result of AML, which typically affects adults. As such, the increasing instances of blood disorders are facilitating the growth of the hematocrit test devices market.

Which Segments in the Hematocrit Test Devices Offer the Most Growth?

The hematocrit test devicesmarket covered in this report is segmented –

1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables

2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications

3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users

Subsegments:

1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters

2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers

3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15582&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Hematocrit Test Devices Market?# Market?

North America was the largest region in the hematocrit test devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theHematocrit Test Devices Market’s Growth?

Leaders within the hematocrit test device market, such as Mindray Medical International Limited, are revolutionizing the field with the development of groundbreaking products like complete blood count (CBC) hematology analyzers. These automated devices have the ability to measure and analyze a variety of critical components in the blood such as the red and white blood cells along with platelets. For instance, in March 2022, the China-based medical device company introduced its BC-700 hematology analyzer series, which combines both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. Alongside other models in the range, like the BC-720, BC-760, and BC-780, the BC-700 series enhances medium-volume labs with advanced diagnostic technologies typically found in premium products. Mindray’s SF Cube 3D analysis technology, a feature of the high-end BC-6000 Series, is also incorporated in the more compact BC-700 series. This technology leverages fluorescence and bi-angular laser scatter signals to perform 3D analysis of target cells.

View the full report here:

https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

What Are the Key Elements That Define the Hematocrit Test Devices Market?

Hematocrit test devices refer to medical instruments used to measure the percentage of red blood cells (RBCs) in a person’s total blood volume. These devices are utilized for monitoring chronic conditions, preoperative assessments, detecting blood doping, screening blood donors, managing emergencies, and conducting research and clinical trials.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15582

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the hematocrit test devices market grown in recent years?

The market size of hematocrit test devices has seen robust growth in recent years. It is projected to escalate from $4.63 billion in 2024 to $4.95 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.9%. The expansion during the historical period can be credited to an increase in knowledge about anemia, deficiency of iron and vitamins, a heightened prevalence of chronic diseases, a boost in government subsidies, and a rise in population.

How is the hematocrit test devices market size expected to evolve during the forecast period?

Strong growth is anticipated in the hematocrit test devices market in the coming years, with its size ballooning to $6.37 billion by 2029 at a compound annual growth rate (CAGR) of 6.5%. A range of factors are contributing to this growth, including the increasing incidences of anemia and blood disorders, a rising geriatric population, heightened focus on health and fitness, and an expanding need for cardiovascular diagnostic equipment. Several key trends are expected to shape the market during this period such as the development of innovative technological solutions, advanced medical science techniques, cutting-edge products, technical progress in hematocrit testing, and advancements made in the overall healthcare sector.

Get your hematocrit test devices market report here!

https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

Which key drivers are propelling the hematocrit test devices market’s growth?

The hematocrit test devices market is anticipated to expand due to the increasing instances of blood disorders. Blood disorders relate to conditions impacting human blood components, which could be white or red blood cells, platelets, or blood plasma. These disorders are becoming increasingly prevalent because of genetic susceptibility, environmental contamination, and changes in lifestyle. Hematocrit test apparatuses chiefly serve to calculate the proportion of red blood cells in the complete blood volume, providing essential data on the patient’s hematological condition. For instance, a report published by the American Cancer Society, a non-profit organization based in the United States, in January 2024, estimated approximately 62,770 new leukemia cases in all varieties, forecasted in the United States in 2024, leading to a rough estimation of 23,670 deaths. These cases are set to include around 20,800 new occurrences of acute myeloid leukemia (AML), mostly in adults, with roughly 11,220 deaths ascribed to AML, almost exclusively in adult patients. As such, the rising instances of blood disorders are fueling the expansion of the hematocrit test devices market.

What are the market segments in the hematocrit test devices industry?

The hematocrit test devices market covered in this report is segmented –

1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables

2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications

3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users

Subsegments:

1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters

2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers

3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp

Which leading companies are shaping the growth of the hematocrit test devices market?

Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company (BD), Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, Heska Corporation, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory Lp, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

What key trends are currently impacting the hematocrit test devices market’s development?

Key firms in the hematocrit test device market are pioneering inventive tools like the complete blood count (CBC) hematology analyzers, which provide comprehensive insights into blood cell compositions. The CBC hematology analyzer is a modern machine designed to scrutinize and measure diverse blood components like red blood cells (RBCs), white blood cells (WBCs), and platelets. For example, Mindray Medical International Limited, a medical device firm based in China, in March 2022 unveiled the BC-700 hematology analyzer series. This series features a CBC hematology analyzer that combines both CBC and erythrocyte sedimentation rate (ESR) tests. The BC-700 hematology analyzer, together with the BC-720, BC-760, and BC-780, forms a series specifically designed to equip medium-volume labs with state-of-the-art diagnostic technologies akin to those available in premium products. The BC-700 Series is a smaller version of the elite BC-6000 Series and is recognised by Mindray’s SF Cube 3D analysis technology, which uses fluorescence and bi-angular laser scatter signals to assess target cells in three dimensions.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15582

Which geographic areas are influencing the growth of the hematocrit test devices market?

North America was the largest region in the hematocrit test devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Hematology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

Hemato Oncology Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Projected Compound Annual Growth Rate (CAGR) of the Hematocrit Test Devices Market from 2025 to 2034, and What Factors Influence It?

The market size for hematocrit test devices has seen significant growth in the past few years. The market is projected to expand from $4.63 billion in 2024 to $4.95 billion in 2025, experiencing a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this historic period growth include heightened awareness about anemia, iron and vitamin deficiencies, a rise in chronic diseases, enhanced government funding, and overall population growth.

In the upcoming years, strong expansion is anticipated for the hematocrit test devices market, with its value projected to reach $6.37 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this expected growth include a rise in anemia cases, an increase in blood disorders, a growing elderly population, a heightened emphasis on health and fitness, and an expanding requirement for cardiovascular diagnostic devices. The forecast period will also see major trends like the launch of cutting-edge solutions, technological advancements in medical science, the development of new, efficient, and innovative products, advancements in hematocrit testing technology, and improvements within the healthcare industry.

How Are the key drivers expanding the growth of the Hematocrit Test Devices Market?

The rise in incidences of blood-related ailments is predicted to spur the expansion of the hematocrit test devices market. Blood disorders, which impact human blood components such as red blood cells, white blood cells, platelets, and blood plasma, are growing increasingly frequent due to several factors like genetic pre-dispositions, environmental pollution, and alterations in lifestyle. Hematocrit testing devices are predominantly utilized to calculate the proportionate volume of red blood cells in whole blood, thereby offering essential data about a patient’s blood health. As an illustration, in January 2024, a study by the American Cancer Society, a non-profit organization based in the US, anticipated roughly 62,770 new cases of all types of leukemia in the US in 2024, resulting in approximately 23,670 fatalities. Of these cases, an estimated 20,800 new cases of acute myeloid leukemia (AML) are predicted, majorly infecting adults, with about 11,220 deaths specifically linked to AML, which predominantly impacts adults. Consequently, the increasing incidences of blood disorders are fueling the hematocrit test devices market expansion.

Request Your Free Hematocrit Test Devices Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp

Who Are the Leading Players Fueling Growth in the Hematocrit Test Devices Market?

Major companies operating in the hematocrit test devices market are:

• F. Hoffmann-La Roche Ltd._x000D_

• Merck & Co. Inc._x000D_

• Bayer AG_x000D_

• Thermo Fisher Scientific Inc._x000D_

• Abbott Laboratories_x000D_

What Are the Emerging Trends Shaping the Future of the Hematocrit Test Devices Market?

Leading firms in the hematocrit test device market are devising innovative offerings, such as complete blood count (CBC) hematology analyzers, aimed at delivering both quantitative and qualitative data about blood cells. A CBC hematology analyzer is a mechanized tool used for examining and quantitating different components of blood including red blood cells(RBCs), white blood cells(WBCs), and platelets. An illustration of this is seen in March 2022 when Mindray Medical International Limited, a firm based in China specializing in medical devices, unveiled the BC-700 hematology analyzer series. This is a CBC hematology analyzer that integrates both CBC and erythrocyte sedimentation rate (ESR) tests. The BC-700 hematology analyzer and its equivalent BC-720, BC-760, and BC-780 form a series designed to equip medium-volume laboratories with the sophisticated diagnostic technologies typically seen in premium products. The BC-700 Series, being a smaller version of the elite BC-6000 Series, is constructed on the same platform and features Mindray’s SF Cube 3D analysis technology. The SF Cube technology employs fluorescence and bi-angular laser scatter signals to evaluate target cells in tri-dimensional space.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

What Are the Core Categories and Segments in the Hematocrit Test Devices Market Driving Demand and Growth?

The hematocrit test devices market covered in this report is segmented –

1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables

2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications

3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users

Subsegments:

1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters

2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers

3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables

Which Regions Are Driving Growth in the Hematocrit Test Devices Market?

North America was the largest region in the hematocrit test devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the Hematocrit Test Devices Market?

Hematocrit test devices refer to medical instruments used to measure the percentage of red blood cells (RBCs) in a person’s total blood volume. These devices are utilized for monitoring chronic conditions, preoperative assessments, detecting blood doping, screening blood donors, managing emergencies, and conducting research and clinical trials.

Browse Through More Similar Reports By The Business Research Company:

Hematology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

Hemato Oncology Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

Market Overview and Growth

• Current Market Size: The hematocrit test devices market was valued at $4.35 billion in 2023.
• Projected Growth: Expected to reach $4.63 billion in 2024, with a compound annual growth rate (CAGR) of 6.4%.
• Historic Growth Drivers:
  • Increased awareness of anemia and nutritional deficiencies.
  • Rising incidence of chronic illnesses.
  • Surge in government funding and population growth.

Future Growth Projections

• Forecasted Market Size: Anticipated to grow to $5.98 billion by 2028.
• Future CAGR: Expected to maintain a CAGR of 6.6%.
• Key Growth Factors:
  • Rising prevalence of anemia and blood disorders.
  • Increasing geriatric population and focus on health.
  • Expanding need for cardiovascular diagnostic tools.

View More On The Hematocrit Test Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

Impact of Blood Disorders

• Prevalence of Blood Disorders:
  • Growing due to genetic factors, environmental pollution, and lifestyle changes.
  • Blood disorders impact components like red blood cells, white blood cells, and platelets.
• Market Implications:
  • Hematocrit test devices are crucial for measuring red blood cell volume in whole blood.
  • Example: In January 2024, the American Cancer Society projected around 62,770 new leukemia cases in the U.S., boosting demand for hematocrit testing.

Major Market Players

• Leading Companies:
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Siemens Healthcare GmbH
• Innovative Developments: Companies are introducing advanced solutions and technologies, such as complete blood count (CBC) hematology analyzers.

Innovative Products in the Market

• CBC Hematology Analyzers:
  • Functionality: Measure and analyze red and white blood cells, and platelets.
  • Example: Mindray Medical’s BC-700 Series, featuring advanced SF Cube 3D technology for precise analysis.
• Technological Advancements:
  • Integration of fluorescence and bi-angular laser scatter for detailed cell analysis.

Strategic Moves and Acquisitions

• Mars Incorporated and Heska Corporation:
  • Acquisition: Mars acquired Heska Corporation in June 2023 for $1.3 billion.
  • Impact: Expansion of Mars Petcare’s diagnostic capabilities and enhanced global pet healthcare solutions.

Market Segmentation

• By Product:
  • Hematocrit Test Meter
  • Hematocrit Test Analyzer
  • Reagents and Consumables
• By Application:
  • Anemia
  • Polycythemia Vera
  • Congenital Heart Diseases
  • Other Applications
• By End-User:
  • Hospitals and Ambulatory Surgical Centers
  • Clinics
  • Diagnostic and Pathology Labs
  • Other End-Users

Regional Insights

• Current Leader: North America was the largest market in 2023.
• Future Growth: Asia-Pacific is anticipated to be the fastest-growing region in the forecast period.

Conclusion
The hematocrit test devices market is experiencing robust growth driven by increasing awareness of blood disorders, technological advancements, and strategic acquisitions. With a forecasted rise in market size and the introduction of innovative products, the industry is set for a promising future

Request A Sample Of The Global Hematocrit Test Devices Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15582&type=smp